Inhalation Tuesday, February 20, 2018
Skip Navigation LinksHome) Item Details
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.
Technical Articles
   
Item Details:
Publication Date: 02/2009
Pages: 5
Medium:
PDF Format
US:
$7.50
Recommended Item:
In vitro bioequivalence testing of nasal sprays

Interest in new test methods for bioequivalence of inhaled and nasal drug products is growing - are there alternative ways forward?

A reliance on in vitro testing could aid in the timely approval of generics and could reduce time and expense for the development of novel products. Cost effective and efficient methods to establish bioequivalence would benefit the development of both brand-name and generic pharmaceuticals, saving both companies and consumers significant amounts of money. Much of the current interest in bioequivalence stems from a desire to introduce improved methods of testing to achieve these objectives, and several new, potentially more meaningful, in vitro methods show promise in that area.

To read this entire article:

You may purchase this article now for personal use. Simply click the Buy Item button above, enter your payment details, and download the article. It will be available to you for 7 days for viewing, printing, or saving for future reference. All articles are copyrighted by CSC Publishing, Inc. and cannot be used for commercial purposes without express permission in writing from the Publisher. This includes but is not limited to: web posting, printing, or sharing via email.

Security:

Your payment information is forwarded in an encrypted form, using 40- or 128-bit Secure Socket Layer technology, only to our payment gateway (Authorize.net) for processing.

Acrobat:

To view an article, you must have Acrobat Reader installed on your computer. Click on the icon to download Acrobat Reader free of charge.

HyperLink
      Copyright 2018, CSC Publishing Inc. ALL Rights Reserved * Privacy policy